Elicio Therapeutics reported cash from operations of -$8.16M and free cash flow of -$8.00M for the quarter ended Jun 2026, up 8.8% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -15.76M | 14.63M | -14.48M | -7.30M | -6.84M | -6.00M | -8.14M | -8.45M | -10.53M | -9.32M | -10.13M | -10.84M | -10.30M | -13.71M | -10.70M | -10.12M | -8.27M | -9.18M | -10.85M | -10.70M | ||||||
| Share-based CompensationStock Comp. | 2.18M | 2.02M | 0.03M | 0.24M | 0.11M | 0.20M | 0.22M | 0.28M | 0.34M | 0.34M | 0.32M | 0.35M | 0.31M | 0.46M | 0.52M | 0.71M | 0.70M | 0.77M | 0.87M | 0.94M | ||||||
| Gains from Investment SecuritiesGains Investment | -0.13M | -0.27M | -0.04M | 0.02M | -0.01M | -0.01M | 1.28M | -3.62M | 5.62M | 0.61M | 0.51M | 0.86M | 1.81M | -1.26M | 0.98M | -2.48M | ||||||||||
| Cash from OperationsCash from Ops. | -15.20M | -14.36M | -15.65M | 6.14M | -5.39M | -7.28M | -8.14M | -9.47M | -5.18M | -9.89M | -12.12M | -8.93M | -7.27M | -8.74M | -10.12M | -8.95M | -11.09M | -6.80M | -11.64M | -8.16M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.19M | 0.19M | 0.20M | 0.09M | 0.19M | 0.19M | 0.40M | 0.18M | 0.21M | 0.21M | 0.21M | 0.03M | 0.22M | 0.23M | 0.23M | 0.40M | 0.24M | 0.24M | 0.10M | |||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | ||||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -1.66M | -2.94M | -1.32M | 3.08M | -0.35M | -0.28M | 1.39M | -1.46M | 0.14M | -0.04M | -3.26M | -0.05M | 0.93M | -0.95M | 3.00M | -0.17M | -3.54M | 0.35M | -0.46M | 0.63M | ||||||
| Change in Accured ExpensesChange Accured Exp. | 0.84M | -2.17M | 2.02M | -1.91M | -0.18M | -0.23M | -0.38M | 0.12M | 2.16M | 0.31M | -0.43M | 2.04M | -0.51M | 3.56M | -2.65M | -0.66M | 0.11M | 1.21M | -0.60M | 1.47M | ||||||
| Other Working Capital ChangesOther WC Changes | -1.46M | -25.14M | -1.65M | 1.65M | 2.15M | -0.72M | -0.51M | -0.93M | 1.66M | -0.97M | -0.07M | -0.28M | 0.96M | -0.14M | -0.49M | -0.68M | ||||||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.06M | 0.04M | -0.03M | 0.59M | 0.10M | -0.20M | 0.22M | 0.04M | -0.16M | -1.04M | -1.03M | 0.17M | 0.23M | -0.17M | ||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.03M | 0.00M | ||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.06M | -0.04M | -0.56M | -0.10M | -0.02M | 0.03M | -0.04M | 0.00M | -0.04M | -0.04M | -0.02M | |||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.01M | 0.11M | 0.08M | -0.06M | 0.07M | 0.04M | 0.03M | 0.06M | 5.96M | 16.92M | -16.90M | 0.34M | 0.95M | 0.10M | 0.02M | |||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.70M | 0.40M | -0.01M | 1.26M | 8.78M | 11.18M | 10.04M | 21.51M | 0.06M | 7.00M | 11.02M | 0.32M | 30.75M | 0.23M | 10.33M | 11.93M | 9.57M | 4.86M | 8.03M | 16.51M | ||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -3.07M | 1.17M | 8.84M | 11.11M | 7.00M | 5.06M | 0.30M | 0.05M | -0.86M | 0.83M | 2.02M | |||||||||||||||
| Additional items | ||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.02M | 0.01M | -0.09M | 0.09M | 0.08M | -0.08M | 0.00M | -0.04M | 0.04M | 0.03M | 0.03M | 0.07M | 0.04M | -0.10M | 0.01M | -0.00M | ||||||||||
| Change in Cash | -14.58M | -13.98M | -15.75M | 6.92M | 3.39M | 3.81M | 1.88M | 12.06M | -5.17M | -2.89M | -1.09M | -8.70M | 23.52M | -8.54M | 0.24M | 3.06M | -1.48M | -2.05M | -3.61M | 8.34M | ||||||
| Free Cash FlowFCF | -15.26M | -14.40M | -15.62M | 5.55M | -5.39M | -7.37M | -7.94M | -9.69M | -5.23M | -9.89M | -11.96M | -7.89M | -6.24M | -8.74M | -10.12M | -8.95M | -11.26M | -6.80M | -11.87M | -8.00M | ||||||
| Net Cash FlowNCF | -14.56M | -13.99M | -15.67M | 6.84M | 3.39M | 3.81M | 1.88M | 12.07M | -5.17M | -2.89M | -1.09M | -8.65M | 23.48M | -8.56M | 0.21M | 2.98M | -1.51M | -1.95M | -3.62M | 8.35M |